Stock Name - LINCOLN PHARMA LTDStock Name - LINCOLN PHARMA LTD
- All time high resistance Breakout
- Can enter at retest around 740-760
- Can expect returns of 10-15%- SL of 5-8%
- Good Volume on breakout- #LINCOLN
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
48.90 INR
933.05 M INR
5.72 B INR
9.92 M
About LINCOLN PHARMA LTD
Sector
CEO
Mahendrabhai Gulabda Patel
Headquarters
Ahmedabad
Website
Founded
1979
ISIN
INE405C01035
FIGI
BBG000GMHMS6
Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. It focuses on different sectors such as cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin's, analgesic, and iron preparations. The company was founded in 1979 and is headquartered in Ahmedabad, India.
Lincoln pharma: New techno funda stockWith strong fundamental and undervalued price, LINCOLN PHARMA can be new multibagger.
FIIs increasing stakes, company consistently outperforming market.
Rounding bottom completed. Breakout expected soon. Levels mentioned in chart.
Lincoln Pharma - Taking Support on 200EMA and Trend LineLincoln Pharma Ltd is showing positive technical indicators, with its stock finding support at a trend line and the 200-day EMA, signaling stability and potential growth. These signs indicate a favorable risk to reward ratio, making it an appealing choice for investors looking for balanced potential
14Weeks Cup & HandleThe stock broke out from 14 weeks cup and handle base and broke out with huge volume, fundamental are also looking good, trading at fair value.
LINCOLN - 3 Months consolidation Breakout Lincoln Pharmaceuticals Ltd
1) Time Frame - Weekly.
2) The Stock has been in a consolidation since (November, 2023). Now It has given a consolidation breakout & Closed at it's All Time High with good bullish momentum in Weekly Time Frame.
3) The stock will find it's next resistance around the pric
LINCOLN | Swing Trade📊 DETAILS
Sector: Pharmaceuticals & Drugs
Mkt Cap: 1,395 cr
Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.
TTM PE : 16.00 (High PE)
Sector PE : 55.22
Beta : 0.45
📚 INSIGHTS
Mid-range perfo
LINCOLN basingit is in basing process in the last 60 days.
first dip is 15% from top
second dip is 10% from top.
forming higher lows in the base.
40% prior rally, still showing relative strength to index.
trading above short term moving average. check out results today.
LINCOLN Perfect Breakout Retest candidate.The stock is retesting previous breakout. despite fall in market pharma stocks are holding strong.
Supporting SMA 30 and SMA 50.
No significant weakness in last two days fall.
Some profit booking startedLast month outperformed this counter in pharma space
Now it's time to some consolidation and profit booking sign visible
If 625 break then I m exit from this counter
LINCOLN - Long Setup, Move is ON..NSE:LINCOLN
✅ #LINCOLN trading above Resistance of 600
✅ Next Resistance is at 774
Related charts:
Charts are self-explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LINCOLN is 616.85 INR — it has decreased by −2.03% in the past 24 hours. Watch LINCOLN PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange LINCOLN PHARMA LTD stocks are traded under the ticker LINCOLN.
LINCOLN stock has fallen by −10.21% compared to the previous week, the month change is a −7.74% fall, over the last year LINCOLN PHARMA LTD has showed a 2.28% increase.
LINCOLN reached its all-time high on Sep 10, 2024 with the price of 811.85 INR, and its all-time low was 85.05 INR and was reached on Mar 19, 2020. View more price dynamics on LINCOLN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LINCOLN stock is 7.57% volatile and has beta coefficient of 0.65. Track LINCOLN PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is LINCOLN PHARMA LTD there?
Today LINCOLN PHARMA LTD has the market capitalization of 12.31 B, it has decreased by −4.27% over the last week.
Yes, you can track LINCOLN PHARMA LTD financials in yearly and quarterly reports right on TradingView.
LINCOLN PHARMA LTD is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
LINCOLN net income for the last quarter is 236.72 M INR, while the quarter before that showed 185.97 M INR of net income which accounts for 27.29% change. Track more LINCOLN PHARMA LTD financial stats to get the full picture.
Yes, LINCOLN dividends are paid annually. The last dividend per share was 1.80 INR. As of today, Dividend Yield (TTM)% is 0.29%. Tracking LINCOLN PHARMA LTD dividends might help you take more informed decisions.
LINCOLN PHARMA LTD dividend yield was 0.31% in 2023, and payout ratio reached 3.86%. The year before the numbers were 0.44% and 4.12% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 17, 2024, the company has 1.69 K employees. See our rating of the largest employees — is LINCOLN PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LINCOLN PHARMA LTD EBITDA is 1.02 B INR, and current EBITDA margin is 16.40%. See more stats in LINCOLN PHARMA LTD financial statements.
Like other stocks, LINCOLN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LINCOLN PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LINCOLN PHARMA LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LINCOLN PHARMA LTD stock shows the buy signal. See more of LINCOLN PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.